Integer Holdings Corporation logo

Integer Holdings Corporation

ITGR

NYSEHealthcareMedical - Devices

常规交易时段

US$125.27

+US$0.07 · +0.06%

8月24日 12:29 ET延迟

ITGR公司概览

盘中时间采用ET。市场数据可能有所延迟。

GoAI 研究快照

简明呈现最新可用的模型信息。

2026年7月10日

GoAI评分

Buy

Favorable setup — positive multi-factor alignment

估值

92

Deep Value

动量

46

Neutral

情绪

68

Bullish

风险韧性

70

Moderate Risk

完整 GoAI 研究

继续查看更深入的依据、催化因素和风险。

查看完整研究

人工智能生成的上下文仅供参考,并非投资建议。

公司概况

公司网站

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

行业
Medical - Devices
部门
Healthcare
总部
US
首席执行官
Payman Khales
上市以来
2000年9月29日
雇员
11,000

市场位置

日内区间

当前US$125.27,

52周区间

当前US$125.27,

开盘价
US$125.35
前收盘价
US$125.2
成交量
12.67万
0.16× 平均值
平均成交量
79.12万
日均成交量
市值
42.54亿 USD
贝塔
0.61
市场参考 1
50天平均值
US$104.09
高于平均水平+20.35%
200天平均值
US$87.9805
高于平均水平+42.38%

财务数据

财务快照

最近十二个月

估值与收益率

企业价值
41.07亿 USD
市盈率(TTM)
33.95×
市净率(TTM)
2.48×
市销率(TTM)
2.31×
EV/EBITDA
13.98×
盈利收益率
3.77%
自由现金流收益率
3.86%
股息率
0.00%

盈利能力和效率

毛利率
23.73%
营业利润率
9.47%
净利润率
6.97%
净资产收益率
5.88%
资产收益率
3.01%
投入资本回报率
5.36%

财务健康

负债权益比
0.79×
流动比率
3.32×

ITGR同业公司

持有ITGR的ETF

报告持有此股票敞口的交易所交易基金。

继续GoAI的研究

在 GoAI 中研究ITGR

research.disclaimer